Indonesian Journal of Cancer Chemoprevention

Online ISSN: 2355-8989, Print ISSN: 2088-0197

Indonesian Journal of Cancer Chemoprevention (IJCC) is an open access, peer-reviewed, triannual journal devoted to publishing articles on Cancer Chemoprevention including Experimental and Clinical Pharmacology, especially concerning Anti-Oxidants, Anti-Aging, Anti-Inflammation, Anti-Angiogenesis, and Anti-Carcinogenesis; Cancer Detection; Stem Cell Biology; Immunology; in vitro and in silico Exploration of Chemopreventive Mechanism; and Natural Products.

IJCC is an official journal of the Indonesian Society for Cancer Chemoprevention. All lJCC's materials are free to be copied and redistributed in any medium or format. However, appropriate credit should be given. The material may not be used for commercial purposes. This content licensing is in accordance with a CC license: CC-BY-NC.

IJCC has been accredited by the Ministry of Research, Technology and Higher Education of the Republic of Indonesia.

Announcements

Call for Papers

Indonesian Journal of Cancer Chemoprevention invites you to submit papers, covering any aspect of Experimental and Clinical Pharmacology, especially concerning anti-oxidants, anti-aging, anti-inflammation, anti-angiogenesis, and anti-carcinogenesis; Cancer Detection; Stem Cell Biology; Immunology; in vitro and in silico Exploration of Chemopreventive Mechanism; and Natural Products. All submitted papers must not be previously published and not under consideration for publication elsewhere. Papers may come from any country but must be written in English. Papers may be submitted as research article or review article.

More detail information regarding online submission can be found in the author guidelines

Posted: 2018-02-05

More...

More Announcements...

Vol 15, No 2 (2024)

Front and Back Matters

View or download the Front and Back Matters

PDF

Research Article

Evaluation of the Potential In Vitro effects of Plantago major L. on Wound Healing in Human Umbilical Vein Endothelial Cells (HUVEC)

Latifa Amalia, Retno Murwanti, Triana Hertiani, Kurnia Rahayu Purnomo

PDF

87-95

Molecular Insights into Breast Cancer Treatment: An Integrated Approach of Network Pharmacology and Component Analysis for Lansium parasiticum Bark Extract

Roihatul Mutiah, Rahmi Annisa, Syayida Roisatus Zahiro

PDF

96-107

Structure-based Virtual Screening, and Design of Some Lead Compounds as Inhibitors of Kras-G12D of Pancreatic Cancer

Idris Momohjimoh Ovaku, Stephen Eyije Abechi, Gideon Adamu Shallangwa, Abdullahi Bello Umar, Adamu Uzairu

PDF

108-126

Analysis of SARS-CoV-2 spike-Induced Syncytia with Lifeact-GFP as Biosensor Using High-Content Screening Instrument for Automated Syncytia Counting

Dita Fauziah, Endah Puji Septisetyani, Eti Yerizel, Ria Fajarwati Kastian

PDF

127-136

Prediction of Secondary Metabolite Compounds in Lotus (Nelumbo nucifera Gaertn.) Targeting Androgen-α Receptors for Breast Cancer Treatment Using Molecular Docking

Virginia Heaven Mariboto Siagian, Melsa Destia, Nasywa Putri Andini, Benedicta Andrea Yustiandini, Bagus Adhinagoro, Shela Salsabila, Muchtaridi Muchtaridi

PDF

137-149

Rosmarinic Acid from Orthosiphon aristatus Potentially Targets Estrogen Receptor-Alpha in Breast Cancer: In-silico Study

Ghina Alya Putri Qurrotaayun, Joy Elizabeth Nauli Sitompul, Naya Fadhilah, Fransisca Widi Pramudita, Nazwa Septiriana Putri, Fajar Oktavian Muljono, Firghi Muhammad Fardhan, Dhania Novitasari

PDF

150-161